Unity BiotechnologyUNBX

13F holders, Q2 2024 (June 30)
39holders −1
6new positions
7sold out
3famous investors
$1.35avg. 13F price*

At the end of Q2 2024, 39 institutions reported holding Unity Biotechnology Inc. (UNBX) in their 13F filings, down 1 from Q1 2024. 6 opened new positions and 7 sold out. The largest holders were ARCH Venture Management, LLC ($1.4M), Alyeska Investment Group, L.P. ($1.2M) and Vanguard Group Inc. ($798K). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Unity Biotechnology Inc.
CUSIP
91381U200
Latest filing quarter
Q3 2025

History

Number of 13F holders

010203040 Q1 2024: 40Q1 2024Q2 2024: 39Q2 2024Q3 2024: 38Q3 2024Q4 2024: 37Q4 2024Q1 2025: 40Q1 2025Q2 2025: 35Q2 2025Q3 2025: 6Q3 2025

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions6$2K
Exits7$94K

All 13F filers, Q1 2024 → Q2 2024: 68,760 shares bought and 200,547 shares sold, net −131,787 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 39 holders

ARCH Venture Management, LLC 0.51% No change 1,004,817 $1.4M
Alyeska Investment Group, L.P. 0.01% No change 920,013 $1.2M
Vanguard Group Inc. 0.00% Add +6.0% 590,770 $798K
Geode Capital Management, LLC 0.00% Add +11.1% 149,043 $201K
Mayo Clinic 5.53% No change 124,081 $168K
BlackRock Inc. 0.00% Reduce -21.3% 88,385 $119K
Citadel Advisors 0.00% Reduce -22.9% 72,208 $97K
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.00% Add +2.3% 71,983 $97K
Renaissance Technologies 0.00% Reduce -39.6% 64,582 $87K
Morgan Stanley 0.00% Add +42.2% 53,208 $72K
Founders Fund V Management, LLC 7.85% No change 49,172 $66K
Wells Fargo & Company 0.00% Reduce -0.3% 43,402 $59K
Cercano Management LLC 0.00% No change 41,238 $56K
State Street Corp. 0.00% No change 37,824 $51K
Bridgeway Capital Management, LLC 0.00% Reduce -50.0% 25,000 $34K
Commonwealth Equity Services, LLC 0.00% No change 24,612 $33K
Northern Trust Corp. 0.00% Reduce -0.1% 22,549 $30K
Susquehanna International Group, LLP 0.00% Add +8.5% 17,837 $24K
Endowment Wealth Management, Inc. 0.01% No change 13,495 $18K
Osaic Holdings, Inc. 0.00% Reduce -0.2% 13,063 $18K
Millennium Management 0.00% Reduce -72.2% 10,479 $14K
Tower Research Capital LLC (TRC) 0.00% Reduce -2.3% 4,799 $6K
Steward Partners Investment Advisory, LLC 0.00% Reduce -44.8% 3,500 $5K
Glen Eagle Advisors, LLC 0.00% No change 1,104 $1K
JPMorgan Chase & Co. 0.00% Add +188.9% 783 $1K
Simplex Trading, LLC 0.00% Reduce -26.5% 1,187 $1K
Cwm, LLC 0.00% New 500 $1K
Activest Wealth Management 0.00% New 200 $270
Signaturefd, LLC 0.00% No change 200 $270
Rhumbline Advisers 0.00% No change 129 $174
Bank of America Corp. 0.00% New 125 $169
Carmichael Hill & Associates, Inc. 0.00% No change 100 $135
Ameritas Investment Partners, Inc. 0.00% No change 100 $135
AllSquare Wealth Management LLC 0.00% No change 55 $74
HHM Wealth Advisors, LLC 0.00% New 25 $34
Redwood Wealth Management Group, LLC 0.00% New 20 $27
Farther Finance Advisors, LLC 0.00% New 20 $27
Qube Research & Technologies Ltd 0.00% No change 18 $25
Royal Bank of Canada 0.00% Add +177.3% 391 $0

"% of holder's portfolio" is UNBX's weight in each manager's 13F, not the share of Unity Biotechnology Inc. the manager owns.